骨膜蛋白和赖氨酰氧化酶样蛋白 2 在食管鳞状细胞癌中的过表达。
Overexpression of periostin and lumican in esophageal squamous cell carcinoma.
机构信息
Institute of Bioinformatics, International Technology Park, Bangalore 560066, India.
出版信息
Cancers (Basel). 2010 Mar 1;2(1):133-42. doi: 10.3390/cancers2010133.
To identify biomarkers for early detection for esophageal squamous cell carcinoma (ESCC), we previously carried out a genome-wide gene expression profiling study using an oligonucleotide microarray platform. This analysis led to identification of several transcripts that were significantly upregulated in ESCC compared to the adjacent normal epithelium. In the current study, we performed immunohistochemical analyses of protein products for two candidates genes identified from the DNA microarray analysis, periostin (POSTN) and lumican (LUM), using tissue microarrays. Increased expression of both periostin and lumican was observed in 100% of 137 different ESCC samples arrayed on tissue microarrays. Increased expression of periostin and lumican was observed in carcinoma as well as in stromal cell in the large majority of cases. These findings suggest that these candidates can be investigated in the sera of ESCC patients using ELISA or multiple reaction monitoring (MRM) type assays to further explore their utility as biomarkers.
为了鉴定食管鳞状细胞癌(ESCC)的早期检测生物标志物,我们先前使用寡核苷酸微阵列平台进行了全基因组基因表达谱研究。该分析导致鉴定出与相邻正常上皮相比在 ESCC 中显著上调的几个转录本。在本研究中,我们使用组织微阵列对从 DNA 微阵列分析中鉴定出的两个候选基因(骨桥蛋白(POSTN)和亮氨酸丰富重复蛋白聚糖 1(LUM))的蛋白产物进行了免疫组织化学分析。在组织微阵列上排列的 137 种不同的 ESCC 样本中,均观察到骨桥蛋白和亮氨酸丰富重复蛋白聚糖 1 的表达增加。在大多数情况下,在癌和基质细胞中均观察到骨桥蛋白和亮氨酸丰富重复蛋白聚糖 1 的表达增加。这些发现表明,可以使用 ELISA 或多重反应监测(MRM)型测定法在 ESCC 患者的血清中进一步研究这些候选物,以探索它们作为生物标志物的实用性。
相似文献
Cancers (Basel). 2010-3-1
Acta Histochem. 2012-5-5
Cancer Genet Cytogenet. 2009-10
引用本文的文献
World J Clin Oncol. 2021-7-24
Exp Ther Med. 2020-10
Cancer Biol Ther. 2011-9-15
本文引用的文献
Gastroenterology. 2009-10
Nucleic Acids Res. 2009-1
J Cell Commun Signal. 2008-7-20
J Clin Pathol. 2008-4
Pathology. 2007-6